Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/876,794external-prioritypatent/US5985611A/en
Application filed by Univ WashingtonfiledCriticalUniv Washington
Publication of NO944126D0publicationCriticalpatent/NO944126D0/en
Publication of NO944126LpublicationCriticalpatent/NO944126L/en
Micro-Organisms Or Cultivation Processes Thereof
(AREA)
Abstract
Forbedrede fremgangsmåter for rekombinant fremstilling av menneskers reproduksjonshormoner er beskrevet. Disse frem- gangsmåter medfører anvendelsen av dyre-avlede celler som inneholder regulerte sekresjonsgranuler som vertsceller for ekspresjonssystemer istand til å uttrykke DNA som koder for reproduktive menneske-hormoner eller deres B-underenheter.Improved methods for the recombinant production of human reproductive hormones are described. These procedures involve the use of animal-derived cells containing regulated secretion granules as host cells for expression systems capable of expressing DNA encoding reproductive human hormones or their B subunits.
NO944126A1992-04-301994-10-28
Improved production of reproductive hormones
NO944126L
(en)
Analogs of human erythropoietin, DNA sequences encoding them, eukaryotic host cell transfected with the DNA sequences, preparations comprising the analogs, use of the analogues to increase hematocrit, and method of preparing the analogs.
A PURIFIED ISOLATED NUCLEIC ACID, A RECOMBINING VECTOR OF EXPRESSION THAT UNDERSTANDS IT, A CELL THAT INCLUDES SUCH A VECTOR, A METHOD FOR THE PRODUCTION OF A H.PYLORI POLYPEPTIDE, A COMPOSITION OF A VACCINE, A PREPARED COMPOSITION PURIFIED BY H.
DNA sequence, vector, transformed eukaryotic or prokaryotic host cells, processes for producing a protein, polypeptide, antibody, isolation and identification method, pharmaceutical composition and screening method.
DNA sequence encoding protein with IRF-1 activity, expression vector containing it, use of IRF-1 to increase expression, host cell transformed with the expression vector, and protein with IRF-1 activity